Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
NORPHARMCO Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NORPHARMCO IncfiledCriticalNORPHARMCO Inc
Priority to CA 2120045priorityCriticalpatent/CA2120045C/en
Publication of CA2120045A1publicationCriticalpatent/CA2120045A1/en
Application grantedgrantedCritical
Publication of CA2120045CpublicationCriticalpatent/CA2120045C/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Polysaccharides And Polysaccharide Derivatives
(AREA)
Abstract
For the prevention of the narrowing of the tubular walls of an animal after the tubular walls have been traumatized, the administration of a therapeutically effective non-toxic amount of hyaluronic acid and/or salts thereof and/or homologues, analogues, derivatives, complexes, esters, fragments, and subunits of hyaluronic acid to the animal to prevent narrowing of the tubular walls.
CA 21200451994-03-251994-03-25Use of hyaluronic acid and forms to prevent arterial restenosis
Expired - LifetimeCA2120045C
(en)
Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient